The Human Recombinant Insulin market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Human Recombinant Insulin market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital accounting for % of the Human Recombinant Insulin global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Rapid-Acting Human Insulin segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Human Recombinant Insulin include Novo Nordisk, Eli Lilly and Company, Sanofi, Julphar Gulf Pharmaceutical Industries, and Bioton, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Human Recombinant Insulin market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
- Rapid-Acting Human Insulin
- Regular (Short Acting) Insulin
- NPH (Intermediate Acting) Insulin
- Long-Acting Human Insulin
- Premixed Human Insulins Insulin
Market segment by Application can be divided into
- Hospital
- Retail Pharmacy
- Online Pharmacies
- Other
The key market players for global Human Recombinant Insulin market are listed below:
- Novo Nordisk
- Eli Lilly and Company
- Sanofi
- Julphar Gulf Pharmaceutical Industries
- Bioton
- Gan & Lee Pharmaceuticals
- Zhuhai United Laboratories
- Biocon
- Wanbang Biopharmaceuticals
- Dongbao Enterprise Group
- PeproTech
Market segment by region, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Human Recombinant Insulin product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Human Recombinant Insulin, with price, sales, revenue and global market share of Human Recombinant Insulin from 2019 to 2022.
Chapter 3, the Human Recombinant Insulin competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Human Recombinant Insulin breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Human Recombinant Insulin market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Human Recombinant Insulin.
Chapter 13, 14, and 15, to describe Human Recombinant Insulin sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Global Human Recombinant Insulin Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
Table of Contents
1 Market Overview
1.1 Human Recombinant Insulin Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Human Recombinant Insulin Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Rapid-Acting Human Insulin
1.2.3 Regular (Short Acting) Insulin
1.2.4 NPH (Intermediate Acting) Insulin
1.2.5 Long-Acting Human Insulin
1.2.6 Premixed Human Insulins Insulin
1.3 Market Analysis by Application
1.3.1 Overview: Global Human Recombinant Insulin Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacies
1.3.5 Other
1.4 Global Human Recombinant Insulin Market Size & Forecast
1.4.1 Global Human Recombinant Insulin Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Human Recombinant Insulin Sales in Volume (2017-2028)
1.4.3 Global Human Recombinant Insulin Price (2017-2028)
1.5 Global Human Recombinant Insulin Production Capacity Analysis
1.5.1 Global Human Recombinant Insulin Total Production Capacity (2017-2028)
1.5.2 Global Human Recombinant Insulin Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Human Recombinant Insulin Market Drivers
1.6.2 Human Recombinant Insulin Market Restraints
1.6.3 Human Recombinant Insulin Trends Analysis
2 Manufacturers Profiles
2.1 Novo Nordisk
2.1.1 Novo Nordisk Details
2.1.2 Novo Nordisk Major Business
2.1.3 Novo Nordisk Human Recombinant Insulin Product and Services
2.1.4 Novo Nordisk Human Recombinant Insulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Eli Lilly and Company
2.2.1 Eli Lilly and Company Details
2.2.2 Eli Lilly and Company Major Business
2.2.3 Eli Lilly and Company Human Recombinant Insulin Product and Services
2.2.4 Eli Lilly and Company Human Recombinant Insulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Sanofi
2.3.1 Sanofi Details
2.3.2 Sanofi Major Business
2.3.3 Sanofi Human Recombinant Insulin Product and Services
2.3.4 Sanofi Human Recombinant Insulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Julphar Gulf Pharmaceutical Industries
2.4.1 Julphar Gulf Pharmaceutical Industries Details
2.4.2 Julphar Gulf Pharmaceutical Industries Major Business
2.4.3 Julphar Gulf Pharmaceutical Industries Human Recombinant Insulin Product and Services
2.4.4 Julphar Gulf Pharmaceutical Industries Human Recombinant Insulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Bioton
2.5.1 Bioton Details
2.5.2 Bioton Major Business
2.5.3 Bioton Human Recombinant Insulin Product and Services
2.5.4 Bioton Human Recombinant Insulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Gan & Lee Pharmaceuticals
2.6.1 Gan & Lee Pharmaceuticals Details
2.6.2 Gan & Lee Pharmaceuticals Major Business
2.6.3 Gan & Lee Pharmaceuticals Human Recombinant Insulin Product and Services
2.6.4 Gan & Lee Pharmaceuticals Human Recombinant Insulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Zhuhai United Laboratories
2.7.1 Zhuhai United Laboratories Details
2.7.2 Zhuhai United Laboratories Major Business
2.7.3 Zhuhai United Laboratories Human Recombinant Insulin Product and Services
2.7.4 Zhuhai United Laboratories Human Recombinant Insulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Biocon
2.8.1 Biocon Details
2.8.2 Biocon Major Business
2.8.3 Biocon Human Recombinant Insulin Product and Services
2.8.4 Biocon Human Recombinant Insulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Wanbang Biopharmaceuticals
2.9.1 Wanbang Biopharmaceuticals Details
2.9.2 Wanbang Biopharmaceuticals Major Business
2.9.3 Wanbang Biopharmaceuticals Human Recombinant Insulin Product and Services
2.9.4 Wanbang Biopharmaceuticals Human Recombinant Insulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Dongbao Enterprise Group
2.10.1 Dongbao Enterprise Group Details
2.10.2 Dongbao Enterprise Group Major Business
2.10.3 Dongbao Enterprise Group Human Recombinant Insulin Product and Services
2.10.4 Dongbao Enterprise Group Human Recombinant Insulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 PeproTech
2.11.1 PeproTech Details
2.11.2 PeproTech Major Business
2.11.3 PeproTech Human Recombinant Insulin Product and Services
2.11.4 PeproTech Human Recombinant Insulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Human Recombinant Insulin Breakdown Data by Manufacturer
3.1 Global Human Recombinant Insulin Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Human Recombinant Insulin Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Human Recombinant Insulin
3.4 Market Concentration Rate
3.4.1 Top 3 Human Recombinant Insulin Manufacturer Market Share in 2021
3.4.2 Top 6 Human Recombinant Insulin Manufacturer Market Share in 2021
3.5 Global Human Recombinant Insulin Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Human Recombinant Insulin Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Human Recombinant Insulin Market Size by Region
4.1.1 Global Human Recombinant Insulin Sales in Volume by Region (2017-2028)
4.1.2 Global Human Recombinant Insulin Revenue by Region (2017-2028)
4.2 North America Human Recombinant Insulin Revenue (2017-2028)
4.3 Europe Human Recombinant Insulin Revenue (2017-2028)
4.4 Asia-Pacific Human Recombinant Insulin Revenue (2017-2028)
4.5 South America Human Recombinant Insulin Revenue (2017-2028)
4.6 Middle East and Africa Human Recombinant Insulin Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Human Recombinant Insulin Sales in Volume by Type (2017-2028)
5.2 Global Human Recombinant Insulin Revenue by Type (2017-2028)
5.3 Global Human Recombinant Insulin Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Human Recombinant Insulin Sales in Volume by Application (2017-2028)
6.2 Global Human Recombinant Insulin Revenue by Application (2017-2028)
6.3 Global Human Recombinant Insulin Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Human Recombinant Insulin Sales by Type (2017-2028)
7.2 North America Human Recombinant Insulin Sales by Application (2017-2028)
7.3 North America Human Recombinant Insulin Market Size by Country
7.3.1 North America Human Recombinant Insulin Sales in Volume by Country (2017-2028)
7.3.2 North America Human Recombinant Insulin Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Human Recombinant Insulin Sales by Type (2017-2028)
8.2 Europe Human Recombinant Insulin Sales by Application (2017-2028)
8.3 Europe Human Recombinant Insulin Market Size by Country
8.3.1 Europe Human Recombinant Insulin Sales in Volume by Country (2017-2028)
8.3.2 Europe Human Recombinant Insulin Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Human Recombinant Insulin Sales by Type (2017-2028)
9.2 Asia-Pacific Human Recombinant Insulin Sales by Application (2017-2028)
9.3 Asia-Pacific Human Recombinant Insulin Market Size by Region
9.3.1 Asia-Pacific Human Recombinant Insulin Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Human Recombinant Insulin Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Human Recombinant Insulin Sales by Type (2017-2028)
10.2 South America Human Recombinant Insulin Sales by Application (2017-2028)
10.3 South America Human Recombinant Insulin Market Size by Country
10.3.1 South America Human Recombinant Insulin Sales in Volume by Country (2017-2028)
10.3.2 South America Human Recombinant Insulin Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Human Recombinant Insulin Sales by Type (2017-2028)
11.2 Middle East & Africa Human Recombinant Insulin Sales by Application (2017-2028)
11.3 Middle East & Africa Human Recombinant Insulin Market Size by Country
11.3.1 Middle East & Africa Human Recombinant Insulin Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Human Recombinant Insulin Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Human Recombinant Insulin and Key Manufacturers
12.2 Manufacturing Costs Percentage of Human Recombinant Insulin
12.3 Human Recombinant Insulin Production Process
12.4 Human Recombinant Insulin Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Human Recombinant Insulin Typical Distributors
13.3 Human Recombinant Insulin Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of Tables
Table 1. Global Human Recombinant Insulin Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Human Recombinant Insulin Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 4. Novo Nordisk Major Business
Table 5. Novo Nordisk Human Recombinant Insulin Product and Services
Table 6. Novo Nordisk Human Recombinant Insulin Sales (K Litre), Price (USD/Litre), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table 8. Eli Lilly and Company Major Business
Table 9. Eli Lilly and Company Human Recombinant Insulin Product and Services
Table 10. Eli Lilly and Company Human Recombinant Insulin Sales (K Litre), Price (USD/Litre), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Sanofi Basic Information, Manufacturing Base and Competitors
Table 12. Sanofi Major Business
Table 13. Sanofi Human Recombinant Insulin Product and Services
Table 14. Sanofi Human Recombinant Insulin Sales (K Litre), Price (USD/Litre), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Julphar Gulf Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 16. Julphar Gulf Pharmaceutical Industries Major Business
Table 17. Julphar Gulf Pharmaceutical Industries Human Recombinant Insulin Product and Services
Table 18. Julphar Gulf Pharmaceutical Industries Human Recombinant Insulin Sales (K Litre), Price (USD/Litre), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Bioton Basic Information, Manufacturing Base and Competitors
Table 20. Bioton Major Business
Table 21. Bioton Human Recombinant Insulin Product and Services
Table 22. Bioton Human Recombinant Insulin Sales (K Litre), Price (USD/Litre), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Gan & Lee Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 24. Gan & Lee Pharmaceuticals Major Business
Table 25. Gan & Lee Pharmaceuticals Human Recombinant Insulin Product and Services
Table 26. Gan & Lee Pharmaceuticals Human Recombinant Insulin Sales (K Litre), Price (USD/Litre), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Zhuhai United Laboratories Basic Information, Manufacturing Base and Competitors
Table 28. Zhuhai United Laboratories Major Business
Table 29. Zhuhai United Laboratories Human Recombinant Insulin Product and Services
Table 30. Zhuhai United Laboratories Human Recombinant Insulin Sales (K Litre), Price (USD/Litre), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Biocon Basic Information, Manufacturing Base and Competitors
Table 32. Biocon Major Business
Table 33. Biocon Human Recombinant Insulin Product and Services
Table 34. Biocon Human Recombinant Insulin Sales (K Litre), Price (USD/Litre), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Wanbang Biopharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 36. Wanbang Biopharmaceuticals Major Business
Table 37. Wanbang Biopharmaceuticals Human Recombinant Insulin Product and Services
Table 38. Wanbang Biopharmaceuticals Human Recombinant Insulin Sales (K Litre), Price (USD/Litre), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Dongbao Enterprise Group Basic Information, Manufacturing Base and Competitors
Table 40. Dongbao Enterprise Group Major Business
Table 41. Dongbao Enterprise Group Human Recombinant Insulin Product and Services
Table 42. Dongbao Enterprise Group Human Recombinant Insulin Sales (K Litre), Price (USD/Litre), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. PeproTech Basic Information, Manufacturing Base and Competitors
Table 44. PeproTech Major Business
Table 45. PeproTech Human Recombinant Insulin Product and Services
Table 46. PeproTech Human Recombinant Insulin Sales (K Litre), Price (USD/Litre), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Global Human Recombinant Insulin Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Litre)
Table 48. Global Human Recombinant Insulin Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 49. Market Position of Manufacturers in Human Recombinant Insulin, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 50. Global Human Recombinant Insulin Production Capacity by Company, (K Litre): 2020 VS 2021
Table 51. Head Office and Human Recombinant Insulin Production Site of Key Manufacturer
Table 52. Human Recombinant Insulin New Entrant and Capacity Expansion Plans
Table 53. Human Recombinant Insulin Mergers & Acquisitions in the Past Five Years
Table 54. Global Human Recombinant Insulin Sales by Region (2017-2022) & (K Litre)
Table 55. Global Human Recombinant Insulin Sales by Region (2023-2028) & (K Litre)
Table 56. Global Human Recombinant Insulin Revenue by Region (2017-2022) & (USD Million)
Table 57. Global Human Recombinant Insulin Revenue by Region (2023-2028) & (USD Million)
Table 58. Global Human Recombinant Insulin Sales by Type (2017-2022) & (K Litre)
Table 59. Global Human Recombinant Insulin Sales by Type (2023-2028) & (K Litre)
Table 60. Global Human Recombinant Insulin Revenue by Type (2017-2022) & (USD Million)
Table 61. Global Human Recombinant Insulin Revenue by Type (2023-2028) & (USD Million)
Table 62. Global Human Recombinant Insulin Price by Type (2017-2022) & (USD/Litre)
Table 63. Global Human Recombinant Insulin Price by Type (2023-2028) & (USD/Litre)
Table 64. Global Human Recombinant Insulin Sales by Application (2017-2022) & (K Litre)
Table 65. Global Human Recombinant Insulin Sales by Application (2023-2028) & (K Litre)
Table 66. Global Human Recombinant Insulin Revenue by Application (2017-2022) & (USD Million)
Table 67. Global Human Recombinant Insulin Revenue by Application (2023-2028) & (USD Million)
Table 68. Global Human Recombinant Insulin Price by Application (2017-2022) & (USD/Litre)
Table 69. Global Human Recombinant Insulin Price by Application (2023-2028) & (USD/Litre)
Table 70. North America Human Recombinant Insulin Sales by Country (2017-2022) & (K Litre)
Table 71. North America Human Recombinant Insulin Sales by Country (2023-2028) & (K Litre)
Table 72. North America Human Recombinant Insulin Revenue by Country (2017-2022) & (USD Million)
Table 73. North America Human Recombinant Insulin Revenue by Country (2023-2028) & (USD Million)
Table 74. North America Human Recombinant Insulin Sales by Type (2017-2022) & (K Litre)
Table 75. North America Human Recombinant Insulin Sales by Type (2023-2028) & (K Litre)
Table 76. North America Human Recombinant Insulin Sales by Application (2017-2022) & (K Litre)
Table 77. North America Human Recombinant Insulin Sales by Application (2023-2028) & (K Litre)
Table 78. Europe Human Recombinant Insulin Sales by Country (2017-2022) & (K Litre)
Table 79. Europe Human Recombinant Insulin Sales by Country (2023-2028) & (K Litre)
Table 80. Europe Human Recombinant Insulin Revenue by Country (2017-2022) & (USD Million)
Table 81. Europe Human Recombinant Insulin Revenue by Country (2023-2028) & (USD Million)
Table 82. Europe Human Recombinant Insulin Sales by Type (2017-2022) & (K Litre)
Table 83. Europe Human Recombinant Insulin Sales by Type (2023-2028) & (K Litre)
Table 84. Europe Human Recombinant Insulin Sales by Application (2017-2022) & (K Litre)
Table 85. Europe Human Recombinant Insulin Sales by Application (2023-2028) & (K Litre)
Table 86. Asia-Pacific Human Recombinant Insulin Sales by Region (2017-2022) & (K Litre)
Table 87. Asia-Pacific Human Recombinant Insulin Sales by Region (2023-2028) & (K Litre)
Table 88. Asia-Pacific Human Recombinant Insulin Revenue by Region (2017-2022) & (USD Million)
Table 89. Asia-Pacific Human Recombinant Insulin Revenue by Region (2023-2028) & (USD Million)
Table 90. Asia-Pacific Human Recombinant Insulin Sales by Type (2017-2022) & (K Litre)
Table 91. Asia-Pacific Human Recombinant Insulin Sales by Type (2023-2028) & (K Litre)
Table 92. Asia-Pacific Human Recombinant Insulin Sales by Application (2017-2022) & (K Litre)
Table 93. Asia-Pacific Human Recombinant Insulin Sales by Application (2023-2028) & (K Litre)
Table 94. South America Human Recombinant Insulin Sales by Country (2017-2022) & (K Litre)
Table 95. South America Human Recombinant Insulin Sales by Country (2023-2028) & (K Litre)
Table 96. South America Human Recombinant Insulin Revenue by Country (2017-2022) & (USD Million)
Table 97. South America Human Recombinant Insulin Revenue by Country (2023-2028) & (USD Million)
Table 98. South America Human Recombinant Insulin Sales by Type (2017-2022) & (K Litre)
Table 99. South America Human Recombinant Insulin Sales by Type (2023-2028) & (K Litre)
Table 100. South America Human Recombinant Insulin Sales by Application (2017-2022) & (K Litre)
Table 101. South America Human Recombinant Insulin Sales by Application (2023-2028) & (K Litre)
Table 102. Middle East & Africa Human Recombinant Insulin Sales by Region (2017-2022) & (K Litre)
Table 103. Middle East & Africa Human Recombinant Insulin Sales by Region (2023-2028) & (K Litre)
Table 104. Middle East & Africa Human Recombinant Insulin Revenue by Region (2017-2022) & (USD Million)
Table 105. Middle East & Africa Human Recombinant Insulin Revenue by Region (2023-2028) & (USD Million)
Table 106. Middle East & Africa Human Recombinant Insulin Sales by Type (2017-2022) & (K Litre)
Table 107. Middle East & Africa Human Recombinant Insulin Sales by Type (2023-2028) & (K Litre)
Table 108. Middle East & Africa Human Recombinant Insulin Sales by Application (2017-2022) & (K Litre)
Table 109. Middle East & Africa Human Recombinant Insulin Sales by Application (2023-2028) & (K Litre)
Table 110. Human Recombinant Insulin Raw Material
Table 111. Key Manufacturers of Human Recombinant Insulin Raw Materials
Table 112. Direct Channel Pros & Cons
Table 113. Indirect Channel Pros & Cons
Table 114. Human Recombinant Insulin Typical Distributors
Table 115. Human Recombinant Insulin Typical Customers
List of Figures
Figure 1. Human Recombinant Insulin Picture
Figure 2. Global Human Recombinant Insulin Revenue Market Share by Type in 2021
Figure 3. Rapid-Acting Human Insulin
Figure 4. Regular (Short Acting) Insulin
Figure 5. NPH (Intermediate Acting) Insulin
Figure 6. Long-Acting Human Insulin
Figure 7. Premixed Human Insulins Insulin
Figure 8. Global Human Recombinant Insulin Revenue Market Share by Application in 2021
Figure 9. Hospital
Figure 10. Retail Pharmacy
Figure 11. Online Pharmacies
Figure 12. Other
Figure 13. Global Human Recombinant Insulin Revenue, (USD Million) & (K Litre): 2017 & 2021 & 2028
Figure 14. Global Human Recombinant Insulin Revenue and Forecast (2017-2028) & (USD Million)
Figure 15. Global Human Recombinant Insulin Sales (2017-2028) & (K Litre)
Figure 16. Global Human Recombinant Insulin Price (2017-2028) & (USD/Litre)
Figure 17. Global Human Recombinant Insulin Production Capacity (2017-2028) & (K Litre)
Figure 18. Global Human Recombinant Insulin Production Capacity by Geographic Region: 2022 VS 2028
Figure 19. Human Recombinant Insulin Market Drivers
Figure 20. Human Recombinant Insulin Market Restraints
Figure 21. Human Recombinant Insulin Market Trends
Figure 22. Global Human Recombinant Insulin Sales Market Share by Manufacturer in 2021
Figure 23. Global Human Recombinant Insulin Revenue Market Share by Manufacturer in 2021
Figure 24. Human Recombinant Insulin Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 25. Top 3 Human Recombinant Insulin Manufacturer (Revenue) Market Share in 2021
Figure 26. Top 6 Human Recombinant Insulin Manufacturer (Revenue) Market Share in 2021
Figure 27. Global Human Recombinant Insulin Sales Market Share by Region (2017-2028)
Figure 28. Global Human Recombinant Insulin Revenue Market Share by Region (2017-2028)
Figure 29. North America Human Recombinant Insulin Revenue (2017-2028) & (USD Million)
Figure 30. Europe Human Recombinant Insulin Revenue (2017-2028) & (USD Million)
Figure 31. Asia-Pacific Human Recombinant Insulin Revenue (2017-2028) & (USD Million)
Figure 32. South America Human Recombinant Insulin Revenue (2017-2028) & (USD Million)
Figure 33. Middle East & Africa Human Recombinant Insulin Revenue (2017-2028) & (USD Million)
Figure 34. Global Human Recombinant Insulin Sales Market Share by Type (2017-2028)
Figure 35. Global Human Recombinant Insulin Revenue Market Share by Type (2017-2028)
Figure 36. Global Human Recombinant Insulin Price by Type (2017-2028) & (USD/Litre)
Figure 37. Global Human Recombinant Insulin Sales Market Share by Application (2017-2028)
Figure 38. Global Human Recombinant Insulin Revenue Market Share by Application (2017-2028)
Figure 39. Global Human Recombinant Insulin Price by Application (2017-2028) & (USD/Litre)
Figure 40. North America Human Recombinant Insulin Sales Market Share by Type (2017-2028)
Figure 41. North America Human Recombinant Insulin Sales Market Share by Application (2017-2028)
Figure 42. North America Human Recombinant Insulin Sales Market Share by Country (2017-2028)
Figure 43. North America Human Recombinant Insulin Revenue Market Share by Country (2017-2028)
Figure 44. United States Human Recombinant Insulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Canada Human Recombinant Insulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Mexico Human Recombinant Insulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Europe Human Recombinant Insulin Sales Market Share by Type (2017-2028)
Figure 48. Europe Human Recombinant Insulin Sales Market Share by Application (2017-2028)
Figure 49. Europe Human Recombinant Insulin Sales Market Share by Country (2017-2028)
Figure 50. Europe Human Recombinant Insulin Revenue Market Share by Country (2017-2028)
Figure 51. Germany Human Recombinant Insulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. France Human Recombinant Insulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. United Kingdom Human Recombinant Insulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Russia Human Recombinant Insulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Italy Human Recombinant Insulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Asia-Pacific Human Recombinant Insulin Sales Market Share by Region (2017-2028)
Figure 57. Asia-Pacific Human Recombinant Insulin Sales Market Share by Application (2017-2028)
Figure 58. Asia-Pacific Human Recombinant Insulin Sales Market Share by Region (2017-2028)
Figure 59. Asia-Pacific Human Recombinant Insulin Revenue Market Share by Region (2017-2028)
Figure 60. China Human Recombinant Insulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Japan Human Recombinant Insulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Korea Human Recombinant Insulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. India Human Recombinant Insulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Southeast Asia Human Recombinant Insulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Australia Human Recombinant Insulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. South America Human Recombinant Insulin Sales Market Share by Type (2017-2028)
Figure 67. South America Human Recombinant Insulin Sales Market Share by Application (2017-2028)
Figure 68. South America Human Recombinant Insulin Sales Market Share by Country (2017-2028)
Figure 69. South America Human Recombinant Insulin Revenue Market Share by Country (2017-2028)
Figure 70. Brazil Human Recombinant Insulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Argentina Human Recombinant Insulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Middle East & Africa Human Recombinant Insulin Sales Market Share by Type (2017-2028)
Figure 73. Middle East & Africa Human Recombinant Insulin Sales Market Share by Application (2017-2028)
Figure 74. Middle East & Africa Human Recombinant Insulin Sales Market Share by Region (2017-2028)
Figure 75. Middle East & Africa Human Recombinant Insulin Revenue Market Share by Region (2017-2028)
Figure 76. Turkey Human Recombinant Insulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Egypt Human Recombinant Insulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Saudi Arabia Human Recombinant Insulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. South Africa Human Recombinant Insulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. Manufacturing Cost Structure Analysis of Human Recombinant Insulin in 2021
Figure 81. Manufacturing Process Analysis of Human Recombinant Insulin
Figure 82. Human Recombinant Insulin Industrial Chain
Figure 83. Sales Channel: Direct Channel vs Indirect Channel
Figure 84. Methodology
Figure 85. Research Process and Data Source
Global Antioxidant Vitamins Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 100
The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
Global Clavulanate Potassium Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 86
The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030.
North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
Global Amoxicillin Sodium Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 84
The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030.
North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
Global Melatonin Supplements Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 106
The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 93
The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
Global Sleeping Pills Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 94
The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
Global Zinc Oral Drops Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 85
The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
Global Zinc Drops Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 85
The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
Global Anti-Infectives Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 78
The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
